PAR EXPECTS TO RESUME SHIPPING OF SOME SOLID DOSAGE PRODUCTS EARLY THE WEEK OF AUG. 21; FDA BEGINS REVIEW OF 30 "MOST PRESCRIBED" GENERICS AUG. 14